MOLECULAR EPIDEMIOLOGY OF DRUG RESISTANCE ASSOCIATED MUTATIONS (RPOB, KATG, INHA, GYRA, RRS, AND EIS) IN MYCOBACTERIUM TUBERCULOSIS ISOLATES
Genetics and Molecular Research · 07.07.2026
DOI: 10.4238/0p69dd94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 07.07.2026. Verfasst von Muqaddas Noor und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Drug-resistant tuberculosis (DR-TB) constitutes a critical public health emergency in Pakistan, with Sindh province bearing a disproportionately high burden. However, comprehensive province-level molecular data on resistance-conferring mutations remain scarce. This study aimed to determine the frequency, spectrum, and distribution of drug resistance-associated mutations (rpoB, katG, inhA, gyrA, rrs, and eis) in Mycobacterium tuberculosis (MTB) isolates from Sindh, Pakistan.
Methods
A hospital-based, multicentre, cross-sectional study was conducted across four tertiary-care hospitals (JPMC and Civil Hospital/DUHS, Karachi; LUH, Hyderabad; PMUH, Nawabshah). A total of 195 MTB isolates from clinically suspected pulmonary TB patients were processed using the NALC–NaOH method and confirmed by GeneXpert MTB/RIF Ultra. Resistance-associated mutations were detected by line probe assay targeting the six resistance genes. Data were analysed using IBM SPSS version 26.0; p < 0.05 was considered statistically significant.
Results
The overall mutational frequencies were: rpoB 37.9% (74/195), inhA 22.1% (43/195), katG 16.4% (32/195), gyrA 11.8% (23/195), rrs 9.2% (18/195), and eis 5.6% (11/195). The predominant mutations were rpoB S531L, katG S315T, inhA −15 C→T, gyrA D94G, rrs A1401G, and eis −14 C→T. Genotypic MDR-TB was identified in 31.8% (62/195) of isolates, while pre-XDR and XDR profiles accounted for 5.6% (11/195) and 6.2% (12/195), respectively. Mutation frequencies did not differ significantly across the four hospitals (p > 0.05), indicating homogeneous province-wide dissemination of resistant strains. Previously treated patients exhibited a significantly higher resistance burden than new cases (p < 0.001).
Conclusion
The high prevalence of first- and second-line resistance mutations confirms the extensive circulation of MDR, pre-XDR, and XDR-TB strains across Sindh. These findings support the expanded deployment of second-line molecular diagnostics, continuous genomic surveillance, and strengthened programmatic interventions, and provide a province-specific baseline for diagnostic validation and evidence-based treatment policy.
Zitieren
APA
Noor, M., Fatima, D. K., Ahmed, D. A., Vaqar, D. A., Khan, D. Z., Hassan, R. J., Faiz, D. S., & Afzal, F. (2026). MOLECULAR EPIDEMIOLOGY OF DRUG RESISTANCE ASSOCIATED MUTATIONS (RPOB, KATG, INHA, GYRA, RRS, AND EIS) IN MYCOBACTERIUM TUBERCULOSIS ISOLATES. Genetics and Molecular Research. https://doi.org/10.4238/0p69dd94
Vancouver
Noor M, Fatima DK, Ahmed DA, Vaqar DA, Khan DZ, Hassan RJ, et al. MOLECULAR EPIDEMIOLOGY OF DRUG RESISTANCE ASSOCIATED MUTATIONS (RPOB, KATG, INHA, GYRA, RRS, AND EIS) IN MYCOBACTERIUM TUBERCULOSIS ISOLATES. Genetics and Molecular Research. 2026. doi:10.4238/0p69dd94
BibTeX
@article{Noor2026,
author = {Noor, Muqaddas and Fatima, Dr Kiran and Ahmed, Dr Ammar and Vaqar, Dr. Abeer and Khan, Dr Zahid and Hassan, Rana Jahanzaib and Faiz, Dr. Samia and Afzal, Fatima},
title = {MOLECULAR EPIDEMIOLOGY OF DRUG RESISTANCE ASSOCIATED MUTATIONS (RPOB, KATG, INHA, GYRA, RRS, AND EIS) IN MYCOBACTERIUM TUBERCULOSIS ISOLATES},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/0p69dd94}
}
EUVIMED